Acceptability, Tolerance, Satiety and Prebiotic Effect of a New Infant Cereal (ACER)

February 22, 2017 updated by: Luis Manuel Sanchez Siles, Hero Institute for Infant Nutrition

Acceptability, Tolerance, Satiety and Prebiotic Effect of a New Infant Cereal in Infant Between 5 and 8 Months of Age, at the Beginning of Complementary Feeding

This study evaluates a new infant cereals on acceptability, tolerance, satiety and prebiotic effect in infants.

Study Overview

Detailed Description

This is a controlled, randomized, prospective, crossover, triple-blind study to evaluate of a new infant cereal with a portion of whole grain flour on sensorial acceptability, gastrointestinal tolerance, satiety and prebiotic effect in healthy infants fron 5 to 8 months of age at the beginning of complementary feeding.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Murcia, Spain, 30100
        • University of Murcia
      • Murcia, Spain, 30120
        • Hospital Virgen de la Arrixaca
      • Murcia, Spain, 30010
        • Quantum Experimental
    • Murcia
      • Alcantarilla, Murcia, Spain, 30820
        • Institute Hero for Infant Nutrition

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 6 months (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy term infant
  • Birth weight 2500-4200 g
  • Tolerance to cow's milk
  • Tolerance to lactose
  • No Breastfeeding at least 4 months of age
  • No use antibiotic at least 2 weeks before recruitments

Exclusion Criteria:

  • Intolerance to gluten (celiac disease)
  • Congenital abnormalities
  • Acute diseases
  • Chronic situation that affect to food intake or metabolism
  • Breastfeeding infant
  • Any food allergy
  • Participation in other study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: QUADRUPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: New Infant Cereal
amount ingested according to pediatricians recommendations
The infants will start the complementary feeding with the infants cereals of this study, the amount of cereal ingested will be free according to pediatricians recommendations.
The infants will start the complementary feeding with the infants cereals of this study, the amount of cereal ingested will be free according to pediatricians recommendations.
ACTIVE_COMPARATOR: Multicereals Infant Cereal
amount ingested according to pediatricians recommendations
The infants will start the complementary feeding with the infants cereals of this study, the amount of cereal ingested will be free according to pediatricians recommendations.
The infants will start the complementary feeding with the infants cereals of this study, the amount of cereal ingested will be free according to pediatricians recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hedonic scale- Sensorial Evaluation
Time Frame: Day 24, day 73
Sensorial acceptability -Differences between groups measured by Hedonic scales (4-points for children and 7-points for adults)
Day 24, day 73

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: Day 1 (Baseline), Day 45, day 93.
Weight (g)
Day 1 (Baseline), Day 45, day 93.
Length
Time Frame: Day 1 (Baseline), Day 45, day 93.
Length (cm)
Day 1 (Baseline), Day 45, day 93.
Head Circumference
Time Frame: Day 1 (Baseline), Day 45, day 93.
Head Circumference (cm)
Day 1 (Baseline), Day 45, day 93.
Gastrointestinal tolerance
Time Frame: Day 7, day 24, day 45, day 52, day 73, day 93
Numbers of Regurgitations, gassiness, rejections- Differences between groups measured by a 1-day record
Day 7, day 24, day 45, day 52, day 73, day 93
Intestinal habits
Time Frame: Day 7, day 24, day 45, day 52, day 73, day 93
Frequency of defecations and stools consistency- Differences between groups measured by 1-day record
Day 7, day 24, day 45, day 52, day 73, day 93
Satiety
Time Frame: Day 7, day 24, day 45, day 52, day 73, day 93
Food intake (amount), crying (time) and sleeping (time)-Differences between groups measured by 1-day record
Day 7, day 24, day 45, day 52, day 73, day 93
Prebiotic effects
Time Frame: Day 1 (baseline), day 45
Microbiome sequencing- Differences between groups measured in collected stools
Day 1 (baseline), day 45

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: David Gil, PhD, Hospital Virgen de la Arrixaca
  • Study Chair: Luis M Sánchez, PhD, Hero

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 1, 2014

Primary Completion (ACTUAL)

February 1, 2017

Study Completion (ACTUAL)

February 1, 2017

Study Registration Dates

First Submitted

May 9, 2016

First Submitted That Met QC Criteria

May 19, 2016

First Posted (ESTIMATE)

May 24, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 23, 2017

Last Update Submitted That Met QC Criteria

February 22, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CT09-14

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe